1.0Sickle Cell Disease Association of America Inc.https://www.sicklecelldisease.orgEmma Dayhttps://www.sicklecelldisease.org/author/emma/Hemanext - Sickle Cell Disease Association of America Inc.rich600338<blockquote class="wp-embedded-content" data-secret="TV9C9ARABV"><a href="https://www.sicklecelldisease.org/scdcares-hemanext/">Hemanext</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.sicklecelldisease.org/scdcares-hemanext/embed/#?secret=TV9C9ARABV" width="600" height="338" title="“Hemanext” — Sickle Cell Disease Association of America Inc." data-secret="TV9C9ARABV" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.sicklecelldisease.org/wp-content/uploads/2022/08/Untitled-design-29.png1920200Hemanext is a member of SCDAA’s SCD C.A.R.E.S. Consortium. Hemanext is a privately held medical technology company based in Lexington, MA that is dedicated to improving transfusion therapy. Visit their website to learn more about the company. Follow Hemanext on social media The SCD C.A.R.E.S. Consortium aims to change the perception of clinical trials and […]